HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Christoph Thorns Selected Research

angiotensin I (1-7)

8/2015Lack of weight gain after angiotensin AT1 receptor blockade in diet-induced obesity is partly mediated by an angiotensin-(1-7)/Mas-dependent pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Christoph Thorns Research Topics

Disease

30Neoplasms (Cancer)
12/2021 - 04/2002
12Lymphoma (Lymphomas)
01/2019 - 07/2002
6Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2019 - 03/2007
5Neoplasm Metastasis (Metastasis)
06/2019 - 09/2014
4Colorectal Neoplasms (Colorectal Cancer)
07/2019 - 02/2013
4Adenocarcinoma
01/2019 - 10/2009
3Obesity
01/2022 - 08/2015
3Carcinoma (Carcinomatosis)
06/2019 - 02/2003
3Carcinogenesis
08/2017 - 04/2002
3Multiple Myeloma
02/2017 - 01/2016
3Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
05/2014 - 09/2008
3Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
09/2002 - 04/2002
2Insulin Resistance
01/2022 - 08/2015
2Genomic Instability
12/2021 - 07/2019
2Aneuploidy (Aneuploid)
07/2019 - 12/2015
2Neuroendocrine Tumors (Neuroendocrine Tumor)
06/2018 - 03/2016
2Erdheim-Chester Disease
03/2018 - 10/2015
246,XY Disorder of Sex Development (Male Pseudohermaphroditism)
01/2017 - 01/2015
2Uterine Cervical Neoplasms (Cancer of the Cervix)
10/2016 - 10/2009
2Body Weight (Weight, Body)
01/2016 - 08/2015
2Weight Gain
01/2016 - 08/2015
2Squamous Cell Carcinoma of Head and Neck
03/2015 - 10/2014
2B-Cell Lymphoma (Lymphoma, B Cell)
10/2014 - 09/2008
2Esophageal Neoplasms (Esophageal Cancer)
09/2014 - 08/2014
2Hodgkin Disease (Hodgkin's Disease)
09/2002 - 07/2002
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2018
1Rheumatoid Arthritis
01/2018
1Ulcerative Colitis
08/2017
1Breast Neoplasms (Breast Cancer)
01/2017
1Amenorrhea
01/2017
1Atherosclerosis
11/2016
1Weight Loss (Weight Reduction)
08/2015
1Bone Diseases (Bone Disease)
06/2015
1Osteosarcoma (Osteogenic Sarcoma)
06/2015
1Lymphadenitis (Adenitis)
04/2015
1Hyperplasia
04/2015
1T-Cell Lymphoma (Lymphoma, T Cell)
04/2015
1Autoimmune Diseases (Autoimmune Disease)
04/2015
1Hypogonadism (Hypergonadotropic Hypogonadism)
01/2015
1Gonadal Dysgenesis (Gonadal Agenesis)
01/2015
1Hematologic Neoplasms (Hematological Malignancy)
01/2015
1Oropharyngeal Neoplasms
10/2014
1Prostatic Neoplasms (Prostate Cancer)
10/2014

Drug/Important Bio-Agent (IBA)

9MicroRNAs (MicroRNA)IBA
01/2019 - 01/2008
7Biomarkers (Surrogate Marker)IBA
01/2019 - 03/2007
5Proteins (Proteins, Gene)FDA Link
12/2021 - 02/2003
5Hemoglobins (Hemoglobin)IBA
03/2015 - 10/2011
4DNA (Deoxyribonucleic Acid)IBA
12/2021 - 12/2014
4ParaffinIBA
02/2017 - 10/2009
3Telmisartan (Micardis)FDA Link
01/2022 - 08/2015
3Angiotensin IIIBA
01/2022 - 09/2005
3Formaldehyde (Formol)FDA Link
02/2017 - 01/2011
2LeptinIBA
01/2022 - 08/2015
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2017 - 10/2016
2Melphalan (Alkeran)FDA LinkGeneric
01/2016 - 01/2016
2Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
01/2004 - 07/2002
2Complementary DNA (cDNA)IBA
09/2002 - 04/2002
1Phenobarbital (Luminal)FDA Link
07/2021
1Hematoxylin (Haematoxylon)IBA
04/2020
1Eosine Yellowish-(YS) (Eosin)IBA
04/2020
1Immunomodulating AgentsIBA
10/2019
1Peptides (Polypeptides)IBA
07/2019
1Calcibiotic Root Canal SealerIBA
07/2019
1Therapeutic UsesIBA
01/2019
1Antinuclear AntibodiesIBA
03/2018
1Methotrexate (Mexate)FDA LinkGeneric
01/2018
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2017
1Testosterone (Sustanon)FDA Link
01/2017
1hydrogen sulfite (bisulfite)IBA
01/2017
1AntibodiesIBA
10/2016
1Progesterone Receptors (Progesterone Receptor)IBA
03/2016
1somatostatin receptor 2IBA
03/2016
1Estrogens (Estrogen)FDA Link
03/2016
1Estrogen ReceptorsIBA
03/2016
1Somatostatin Receptors (Somatostatin Receptor)IBA
03/2016
1thymosin beta(4)IBA
12/2015
1VemurafenibIBA
10/2015
1canakinumabFDA Link
10/2015
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
10/2015
1Type 1 Angiotensin ReceptorIBA
08/2015
1angiotensin I (1-7)IBA
08/2015
1Carrier Proteins (Binding Protein)IBA
06/2015
1Cathepsin DIBA
06/2015
1AndrogensIBA
01/2015
1inhibin BIBA
01/2015
1Hormones (Hormone)IBA
01/2015
1Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA
10/2014
1Genetic Markers (Genetic Marker)IBA
10/2014

Therapy/Procedure

10Therapeutics
04/2020 - 04/2002
4Drug Therapy (Chemotherapy)
03/2015 - 10/2011
2Prostatectomy (Retropubic Prostatectomy)
12/2021 - 10/2014
2Neoadjuvant Therapy
06/2019 - 01/2019
2Precision Medicine
01/2017 - 06/2015
2Radiotherapy
03/2015 - 08/2014
1Time-to-Treatment
01/2018
1Aftercare (After-Treatment)
01/2016
1Colectomy
06/2015
1Restorative Proctocolectomy
06/2015
1Chemoradiotherapy
10/2014